Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Turning on hormone tap could aid osteoporosis fight

17.07.2008
A potential new drug that ‘opens the taps’ for the release of useful hormones could stimulate new bone growth – and may eventually bring relief to osteoporosis sufferers.

The exciting potential of so-called 'negative allosteric modulators' will be put under the microscope at a special symposium at The Federation of European Pharmacological Societies (EPHAR) 2008 Congress at The University of Manchester, UK, yesterday.

European pharmacologists meeting in Manchester will present work that focuses on the stimulation of parathyroids – tiny glands located above the thyroids that control the release of the parathyroid (PTH) hormone into the bloodstream.

When the concentration of calcium is too low in the blood’s plasma, PTH is released and acts on various tissues to increase the level of calcium in the blood. This calcium then activates the calcium sensing receptor on the parathyroid cell, which then reduces PTH release.

The first POSITIVE allosteric modulator was recently introduced into clinical practice for treating patients displaying high levels of PTH in the plasma – such as those with chronic kidney disease on dialysis and those displaying hypercalcaemia with parathyroid cancer. It mimics the effect of calcium on the receptor and so reduces PTH release.

But now attention is switching to NEGATIVE allosteric modulators, which have been shown in pre-clinical trials to block the effect of calcium on the parathyroid cell and thus increase the release of PTH in the serum.

“Daily administration of a negative allosteric modulator of the calcium sensing receptor should promote a sustained increase of PTH in such a way that it will stimulate new bone formation,” said symposium organiser Martial Ruat, a neuropharmacologist at the government-funded Centre National de la Recherche Scientifique in France.

“Now clinical trials will have to demonstrate the effectiveness and suitability of negative allosteric modulators for treating osteoporosis in humans.”

While pharmacologists are excited and encouraged by results so far, Dr Ruat says it will be at least another eight to 10 years before negative allosteric modulators are passed for use in patients “Osteoporosis is a complex disease and the timescale might be rather long,” says Dr Ruat, who is himself carrying out research to learn more about the potential benefits of both negative and positive allosteric modulators.

He added: “The calcium sensing receptor is also found in the kidney, the intestine, in some vascular and bone cells and also in the brain. We still need to identify the roles of this receptor in these tissues before being able to specify novel applications of these drugs.”

Negative and positive allosteric modulators are also being studied by European pharmacologists with a view to identifying the functions of calcium sensing receptors in the control of blood pressure.

Aeron Haworth | alfa
Further information:
http://www.manchester.ac.uk

More articles from Health and Medicine:

nachricht Researchers identify new way to unmask melanoma cells to the immune system
17.01.2018 | Duke University Medical Center

nachricht Study advances gene therapy for glaucoma
17.01.2018 | University of Wisconsin-Madison

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Scientists decipher key principle behind reaction of metalloenzymes

So-called pre-distorted states accelerate photochemical reactions too

What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...

Im Focus: The first precise measurement of a single molecule's effective charge

For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.

Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...

Im Focus: Paradigm shift in Paris: Encouraging an holistic view of laser machining

At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.

No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...

Im Focus: Room-temperature multiferroic thin films and their properties

Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.

Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...

Im Focus: A thermometer for the oceans

Measurement of noble gases in Antarctic ice cores

The oceans are the largest global heat reservoir. As a result of man-made global warming, the temperature in the global climate system increases; around 90% of...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

10th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Münster, 10-11 April 2018

08.01.2018 | Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

 
Latest News

World’s oldest known oxygen oasis discovered

18.01.2018 | Earth Sciences

Uncovering decades of questionable investments

18.01.2018 | Business and Finance

Novel chip-based gene expression tool analyzes RNA quickly and accurately

18.01.2018 | Medical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>